IL1B and neoplasm: Given that PPAR and RXR signaling represent the top inhibited canonical signaling pathways in Figure 4A,B, we further examined how PPAR signaling, PPARα/RXRα activation, and the LPS/IL1-mediated inhibition of the RXR function were altered during tumor progression.